Vivos Therapeutics Schedules Release of Second and Third Quarter 2022 Financial Results and Conference Call

December 16, 2022

https://www.globenewswire.com/news-release/2022/12/16/2575385/0/en/Vivos-Therapeutics-Schedules-Release-of-Second-and-Third-Quarter-2022-Financial-Results-and-Conference-Call.html

HIGHLANDS RANCH, Colo., Dec. 16, 2022 (GLOBE NEWSWIRE) — Vivos Therapeutics, Inc. (“Vivos” or the “Company”) (NASDAQ:VVOS), a medical technology company focused on developing innovative treatments for patients suffering from dentofacial abnormalities and/or mild to moderate obstructive sleep apnea (OSA) and snoring in adults, today announced it plans to release its second and third quarter 2022 financial results after market close on Tuesday, December 20, 2022. The Company will conduct a conference call the same day at 5:00 pm (Eastern Time) to review the results and provide an overview of the Company’s recent milestones and developments.

Read more at globenewswire.com

Related news for (VVOS)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.